ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹3,959 Cr | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr | ₹3,604 Cr |
What is the latest Total Current Liabilities ratio of ALKEM LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹3,959 Cr |
Mar2024 | ₹3,995 Cr |
Mar2023 | ₹3,707 Cr |
Mar2022 | ₹4,805 Cr |
Mar2021 | ₹3,604 Cr |
How is Total Current Liabilities of ALKEM LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3,959 Cr | -0.90 | |
Mar2024 | ₹3,995 Cr | 7.75 | |
Mar2023 | ₹3,707 Cr | -22.85 | |
Mar2022 | ₹4,805 Cr | 33.33 | |
Mar2021 | ₹3,604 Cr | - |
Compare Total Current Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹64,892.6 Cr | 1.4% | 9.1% | -5.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,187.0 Cr | -0.2% | -2.3% | -7.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,282.0 Cr | -1.7% | -8.8% | 27.2% | Stock Analytics | |
CIPLA | ₹128,619.0 Cr | 1.9% | 8.7% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,712.0 Cr | 0.7% | 4.1% | 8.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,577.0 Cr | 1.4% | 2.9% | -10.6% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 1.4% |
9.1% |
-5.9% |
SENSEX | 0.9% |
-1.1% |
0.6% |
You may also like the below Video Courses